SCHEMBL7568170

SCHEMBL7568170

O=C(CCc1ccc(O)c(O)c1)OCCc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
APP P05067 4/20 1.00
YWHAG P61981 1/20 0.76
IAPP P10997 3/20 0.56
ALOX5 P09917 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
CYP19A1 P11511 1/20 0.53
TYR P14679 1/20 0.53
IGF1R P08069 1/20 0.50
ALOX15 P16050 1/20 0.50
LCK P06239 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
BACE1 P56817 1/20 0.48
MET P08581 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12246764 0.94 APP (0.88) APPYWHAGIAPPALOX5TDP1
SCHEMBL490480 0.92 APP (1.00) APPYWHAGIAPPALOX5TDP1
SCHEMBL28150655 0.92 APP (0.84) APPYWHAGIAPPALOX5TDP1
SCHEMBL22353624 0.92 APP (0.84) APPYWHAGIAPPALOX5TDP1
SCHEMBL12246761 0.91 APP (0.83) APPYWHAGIAPPALOX5TDP1
SCHEMBL22577544 0.91 APP (0.83) APPYWHAGIAPPALOX5TDP1
Hydroxytyrosol Butanoate SCHEMBL17299395 0.89 APP (0.79) APPYWHAGIAPPALOX5KDM4E
Hydroxytyrosol Butanoate SCHEMBL31729490 0.89 APP (0.79) APPYWHAGIAPPALOX5KDM4E
SCHEMBL12300533 0.89 APP (0.78) APPYWHAGALOX5MET
SCHEMBL20730239 0.87 APP (0.77) APPYWHAGIAPPALOX5ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640450-B1 Hydroxytyrosol dihydrocaffeate having antioxidant activity and a method for preparing the same SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-05-05 US disclosed
US-10640450-B1 Hydroxytyrosol dihydrocaffeate having antioxidant activity and a method for preparing the same SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-05-05 US disclosed
US-9089499-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions UNIVERSITE JOSEPH FOURIER-GRENOBLE 1 (FR) 2015-07-28 US disclosed
US-9089499-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions UNIVERSITE JOSEPH FOURIER-GRENOBLE 1 (FR) 2015-07-28 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-8481593-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS S.A.S. (FR) 2013-07-09 US disclosed
US-8481593-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS S.A.S. (FR) 2013-07-09 US disclosed
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2011-09-29 US disclosed
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2011-09-29 US disclosed
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2007-08-09 US disclosed
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2007-08-09 US disclosed
EP-0809493-B1 A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS US HEALTH (US) 2002-09-11 EP disclosed
US-5610185-A Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD APP 2129/4885YWHAG 602/4885IAPP 4863/4885
US-10640450-B1 Hydroxytyrosol dihydrocaffeate having antioxidant activity and a method for preparing the same COMT, QDPR, DHODH APP 1724/4885YWHAG 4541/4885IAPP 2312/4885
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions TYR, CUTA, HPD APP 2180/4885YWHAG 580/4885IAPP 4870/4885
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD APP 2180/4885YWHAG 580/4885IAPP 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.